CLICK THERAPEUTICS
Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical needs. Through cognitive and neurobehavioral mechanisms, Click’s Digital Therapeutics™ enable change within individuals, and are designed to be used independently or in conjunction with biomedical treatments. The Clickometrics® adaptive data science platform continuously personalizes user experience to optimize engagement and outcomes. Following a groundbreaking clinical trial, Click�... ��s industry-leading smoking cessation program is available nationwide through a wide variety of payers, providers, and employers. Click’s lead prescription program is entering into a multi-center, randomized, controlled, parallel-group, phase III FDA registration trial for the treatment of Major Depressive Disorder in adults.
CLICK THERAPEUTICS
Industry:
Biotechnology Health Care Medical Device Pharmaceutical Therapeutics
Founded:
2012-04-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.clicktherapeutics.com
Total Employee:
101+
Status:
Active
Total Funding:
926.38 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Font Awesome Global Site Tag Euro Apple Mobile Web App Capable
Similar Organizations
Icosavax
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
VYNE Therapeutics
VYNE Therapeutics is a clinical late-stage biopharmaceutical company developing treatments associated with dermatologic conditions.
Current Advisors List
Board_member
2020-06-01
Board_member
2021-01-01
Board_observer
Board_member
2021-10-01
Board_member
2021-10-01
Current Employees Featured
David Benshoof Klein Founder & CEO @ Click Therapeutics
Founder & CEO
2012-04-01
Maria Forero Seed Investor, Strategic Advisor & Board Observer at Click Therapeutics @ Click Therapeutics
Seed Investor, Strategic Advisor & Board Observer at Click Therapeutics
2014-08-01
Austin Speier Chief Strategy Officer @ Click Therapeutics
Chief Strategy Officer
2018-10-01
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2012-08-06 | ProGevity Neuroscience | ProGevity Neuroscience acquired by Click Therapeutics | N/A |
Investors List
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Click Therapeutics
Hikma Ventures
Hikma Ventures investment in Series B - Click Therapeutics
Revelation Partners
Revelation Partners investment in Series B - Click Therapeutics
Ridgetop Health
Ridgetop Health investment in Series B - Click Therapeutics
H.I.G. BioHealth Partners
H.I.G. BioHealth Partners investment in Series B - Click Therapeutics
Sanofi Ventures
Sanofi Ventures investment in Series B - Click Therapeutics
Health Catalyst Capital
Health Catalyst Capital investment in Series B - Click Therapeutics
K2 HealthVentures
K2 HealthVentures investment in Series B - Click Therapeutics
Accelmed
Accelmed investment in Series B - Click Therapeutics
K2 HealthVentures
K2 HealthVentures investment in Debt Financing - Click Therapeutics
Official Site Inspections
http://www.clicktherapeutics.com Semrush global rank: 3.6 M Semrush visits lastest month: 3.98 K
- Host name: 152.42.154.197
- IP address: 152.42.154.197
- Location: Davidson United States
- Latitude: 35.4993
- Longitude: -80.8486
- Metro Code: 517
- Timezone: America/New_York
- Postal: 28035
More informations about "Click Therapeutics"
Click Therapeutics’s AI-Enabled Platform
Cyber Essentials is a UK government-backed certification that confirms an organization has implemented cybersecurity measures to protect against common cyber threats. This …See details»
Click Therapeutics - Crunchbase Company Profile
Contact Email Info@clicktherapeutics.com Click Therapeutics develops and commercializes software as medical treatments for people with unmet medical …See details»
Partner with Click Therapeutics
We collaborate with organizations dedicated to improving patient outcomes and addressing unmet needs through innovative solutions. Our platform supports the development of prescription …See details»
Click Therapeutics - Digital Therapeutics Alliance
Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for patients with unmet medical needs. Through cognitive and neurobehavioral mechanisms, …See details»
Click Therapeutics, Inc. | LinkedIn
Click Therapeutics, Inc. | 24,990 followers on LinkedIn. Click Therapeutics, Inc., develops, validates, and commercializes software as prescription medical treatments ...See details»
Click Therapeutics - Overview, News & Similar companies
Jan 22, 2024 Click Therapeutics contact info: Phone number: (646) 248-7933 Website: www.clicktherapeutics.com What does Click Therapeutics do? Founded in 2012, Click …See details»
Working At Click Therapeutics: Company Overview and Culture
Mar 14, 2024 clicktherapeutics.com. Organization Type. Private. CEO. David Benshoof Klein. Social Media. Click Therapeutics develops and commercializes software as prescription …See details»
Click Therapeutics - Craft
Click Therapeutics has 5 employees across 4 locations and $25.35 m in total funding,. See insights on Click Therapeutics including office locations, competitors, revenue, financials, …See details»
Click Therapeutics Company Profile | Management and ... - Datanyze
SQL International Organization for Standardization . Java Oracle . C++ ISO/IEC JTC1/SC22/WG21 - The C++ Standards Committee . Ruby Ruby . ...See details»
Contact Us - Click Therapeutics
Our offices. New York. 80 White Street. 3rd floor. New York, New York 10013 View on Google Maps. Boston. 855 Boylston Street. 10th Floor. Boston, Massachusetts 02116 View on Google …See details»
MMS Corporate Partner - Click Therapeutics - Massachusetts …
Click Therapeutics, Inc. develops and commercializes software as prescription medical treatments for patients with unmet medical needs. Through cognitive and neurobehavioral mechanisms, …See details»
New digital therapy collaboration with Click Tx - Boehringer …
Ingelheim, Germany and New York, New York, 19 December 2022 - Boehringer Ingelheim and Click Therapeutics today announced the launch of an expanded collaboration for the …See details»
Click Therapeutics, Inc. Company Information - Funding, Investors, …
Get information on funding, investors, industries, and more for Click Therapeutics, Inc.. See Click Therapeutics, Inc. company profile and funding data.See details»
Partnership-with-clicktherapeutics | Boehringer Ingelheim
Sep 11, 2020 For more information, visit ClickTherapeutics.com. Media Contacts Linda Ruckel Senior Associate Director, Media and Corporate Reputation Boehringer Ingelheim U.S. Media …See details»
Dassault Systèmes Intensifies the MEDIDATA Commitment to …
Mar 19, 2025 VELIZY-VILLACOUBLAY, France — March 19, 2025 — Dassault Systèmes (Euronext Paris: FR0014003TT8, DSY.PA) today announced its investment in Click …See details»
Click Therapeutics Software-Enhanced Drug™ Therapies (Click SE)
Nov 1, 2024 Ask us how we can help you get started today to prepare your organization for the future. Collaborate with us. Products on our platform. CT-152. Rejoyn. Indication. Major …See details»
Click Therapeutics and Boehringer Ingelheim Announce FDA
Jan 4, 2024 Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that the investigational CT-155 prescription digital …See details»
Click Therapeutics (USA) Funding: $946.4M - Medical Startups
Apr 2, 2025 Click Therapeutics is looking to boost work on an online platform of “prescription digital therapeutics.” The company’s leading product is Clickotine, deisgned for smoking …See details»
Click Therapeutics Underscores Its Commitment to Innovation and ...
Apr 2, 2025 pr@clicktherapeutics.com +1.332.222.4177. Related news. View all. 04.15.2025. FDA. CT-132. Migraine. Click Therapeutics Announces FDA Marketing Authorization for CT …See details»
Click Therapeutics - Clinical Trials
Clinical trials are carefully designed research studies that evaluate safety, efficacy and effectiveness of new treatments or interventions. The process involves screening for eligibility, …See details»